Clinical Trial Update: Gabapentin to Treat Itch in Patients With Liver Disease [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating gabapentin to treat itch in patients with liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Cirrhosis
• Liver Disease
• Pruritus

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Liver Disease, Cholestasis | Phase 3 | Status: COMPLETED